Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV001543433 | SCV005384855 | pathogenic | not provided | 2024-04-24 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 34715294, 33057194, 37541188, 36553517, 35982159) |
| Prevention |
RCV004536168 | SCV004113511 | likely pathogenic | NFIA-Related Disorder | 2022-08-26 | criteria provided, single submitter | clinical testing | The NFIA c.1051C>T variant is predicted to result in premature protein termination (p.Arg351*). To our knowledge, this variant has not been previously reported in association with disease. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in NFIA are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
| Laboratoire de Génétique Moléculaire, |
RCV003148991 | SCV003836693 | pathogenic | Brain malformations with or without urinary tract defects | 2020-05-29 | criteria provided, single submitter | clinical testing | |
| Institute of Medical Genetics and Applied Genomics, |
RCV001543433 | SCV001761997 | likely pathogenic | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing |